![]() | Up a level |
2020
Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna-Maria, Cramer, Paula, von Tresckow, Julia, Lange, Elisabeth, Kiehl, Michael, Dreyling, Martin, Rittgen, Matthias, Duerig, Jan, Fischer, Kirsten, Stilgenbauer, Stephan, Wendtner, Clemens, Goede, Valentin, Hallek, Michael and Eichhorst, Barbara (2020). Richter transformation in CLL: a meta-analysis of GCLLSG trials. Leuk. Lymphoma, 61. S. 98 - 101. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Fink, Anna-Maria, Robrecht, Sandra, Bahlo, Jasmin, Fuerstenau, Moritz, Aldaoud, Ali, Hebart, Holger, Jentsch-Ullrich, Kathleen, Doerfel, Steffen, Fischer, Kirsten, Wendtner, Clemens Martin, Noesslinger, Thomas, Ghia, Paolo, Kater, Arnon, Kreuzer, Karl-Anton, Tausch, Eugen, Stilgenbauer, Stephan, Rittgen, Matthias, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2020). Long-term efficacy and safety of maintenance with lenalidomide in patients with chronic lymphocytic leukaemia and a high risk of progression after first-line immunochemotherapy. Leuk. Lymphoma, 61. S. 272 - 274. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
2017
Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Langerbeins, Petra, Engelke, Anja, Fink, Anna-Maria, Fischer, Kirsten, Seiler, Till, von Weikersthal, Ludwig Fischer, Hebart, Holger, Kreuzer, Karl-Anton, Rittgen, Matthias, Kneba, Michael, Wendtner, Clemens, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2017). Sequential treatment with bendamustine, followed by obinutuzumab (GA101) and venetoclax (ABT-199) in patients with chronic lymphocytic leukemia (CLL): results of the CLL2-BAG phase-II-trial of the German CLL study group (GCLLSG). Leuk. Lymphoma, 58. S. 149 - 151. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403